BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6390198)

  • 1. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
    Felson DT; Anderson J
    N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive drugs plus prednisone versus prednisone alone in lupus nephritis.
    N Engl J Med; 1985 Apr; 312(14):921-2. PubMed ID: 3974677
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
    N Engl J Med; 1978 Nov; 299(21):1151-5. PubMed ID: 309095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lupus nephritis: a meta-analysis of clinical trials.
    Bansal VK; Beto JA
    Am J Kidney Dis; 1997 Feb; 29(2):193-9. PubMed ID: 9016889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of treatment in lupus nephritis: effects of prednisone.
    Pollak VE; Dosekun AK
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):170-7. PubMed ID: 7102665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
    Carette S; Klippel JH; Decker JL; Austin HA; Plotz PH; Steinberg AD; Balow JE
    Ann Intern Med; 1983 Jul; 99(1):1-8. PubMed ID: 6344715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV; Dornfeld L; Lee DB; Liebling MR
    J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytostatic treatment of glomerular diseases. IV. The effect of combined immunosuppressive treatment on serum creatinine and proteinuria evaluated by sequential statistical analysis. Report from a Copenhagen study group of renal diseases.
    Balsløv JT; Brun C; Jørgensen F; Jørgensen HE; Larsen M; Larsen S; Lorenzen I; Thomsen AC
    Acta Med Scand; 1978; 203(5):339-44. PubMed ID: 352097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lupus nephritis.
    N Engl J Med; 1986 Aug; 315(7):458-9. PubMed ID: 3736627
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytostatic treatment of glomerular diseases. V. Treatment of glomerulonephritis with cyclophosphamide plus prednisone, azathioprine plus prednisone and cyclophosphamide as monotherapy. A comparative study. A report from a Copenhagen Study Group of Renal Diseases.
    Brahm M; Balsløv JT; Brammer M; Brun C; Gerstoft J; Jørgensen HE; Kamper A; Larsen S; Lorenzen I; Thomsen AC
    Acta Med Scand; 1988; 224(6):605-10. PubMed ID: 3061292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus and its management.
    Fagundus DM; Leroy EC
    J S C Med Assoc; 1993 Nov; 89(11):516-24. PubMed ID: 8258968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease.
    Coplon NS; Diskin CJ; Petersen J; Swenson RS
    N Engl J Med; 1983 Jan; 308(4):186-90. PubMed ID: 6336825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.